Biochemical and clinical aspects of methotrexate neurotoxicity
- PMID: 12714818
- DOI: 10.1159/000069773
Biochemical and clinical aspects of methotrexate neurotoxicity
Abstract
Acute, subacute and chronic neurotoxicity have been observed after the administration of high-dose and/or intrathecal methotrexate (MTX). Acute toxicity is usually transient without permanent damage. Subacute and chronic toxicity are associated with changes in the brain and/or the spinal cord which may be progressive and even lead to coma and death in severe cases. It is believed that MTX can induce direct toxic effects to the CNS by damaging the neuronal tissue. Moreover, MTX interferes with the metabolic pathways of folates, excitatory amino acids, homocysteine, S-adenosylmethionine/S-adenosylhomocysteine, adenosine and biopterins, inducing biochemical alterations which have been associated with neurotoxic symptoms. It has been suggested that acute toxicity is partly mediated by adenosine, whereas homocysteine, S-adenosylmethionine/S-adenosylhomocysteine, excitatory amino acids and biopterins may play an important role in the development of subacute and chronic toxicity. A better understanding of the pathogenesis of MTX neurotoxicity would offer the possibility of developing new therapeutic strategies for its treatment or prevention.
Copyright 2003 S. Karger AG, Basel
Similar articles
-
Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.Int J Clin Pharmacol Ther. 2007 Sep;45(9):504-15. doi: 10.5414/cpp45504. Int J Clin Pharmacol Ther. 2007. PMID: 17907593 Clinical Trial.
-
Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.Pediatr Blood Cancer. 2009 Jan;52(1):26-32. doi: 10.1002/pbc.21827. Pediatr Blood Cancer. 2009. PMID: 19006245
-
Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.Isr Med Assoc J. 2002 Nov;4(11):1050-3. Isr Med Assoc J. 2002. PMID: 12489505 Review.
-
[Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].Rev Neurol. 2012 Jun 16;54(12):712-8. Rev Neurol. 2012. PMID: 22673947 Spanish.
-
Methotrexate-induced neurotoxicity in oncology: Current issues for a classic drug.J Neurol Sci. 2025 Jun 15;473:123514. doi: 10.1016/j.jns.2025.123514. Epub 2025 Apr 23. J Neurol Sci. 2025. PMID: 40328114 Review.
Cited by
-
Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites.J Neurooncol. 2010 May;97(3):425-7. doi: 10.1007/s11060-009-0028-9. Epub 2009 Oct 11. J Neurooncol. 2010. PMID: 19821069
-
Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.J Clin Oncol. 2014 Mar 20;32(9):949-59. doi: 10.1200/JCO.2013.53.0808. Epub 2014 Feb 18. J Clin Oncol. 2014. PMID: 24550419 Free PMC article.
-
Methotrexate-induced subacute myelopathy: a serious but treatable complication.J Clin Exp Hematop. 2023;63(4):251-256. doi: 10.3960/jslrt.23041. J Clin Exp Hematop. 2023. PMID: 38148015 Free PMC article.
-
Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic Leukemia.J Clin Oncol. 2015 Jul 1;33(19):2205-11. doi: 10.1200/JCO.2014.59.0273. Epub 2015 May 18. J Clin Oncol. 2015. PMID: 25987702 Free PMC article.
-
Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia.Blood. 2015 May 28;125(22):3411-9. doi: 10.1182/blood-2015-01-621680. Epub 2015 Mar 26. Blood. 2015. PMID: 25814529 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources